The Clinical Value of Acupuncture for Women with Premature Ovarian Insufficiency: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Jul 26

PMID 39055062

Authors

Hengjie Cao

Huize Li

Guangyao Lin

Xuanling Li

Shimin Liu

Peiqi Li

Chao Cong

Lianwei Xu

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to evaluate the therapeutic implications of acupuncture on improving ovarian function in women diagnosed with premature ovarian insufficiency (POI) through the implementation of randomized clinical trials (RCTs).

Methods: A comprehensive search of eight databases was conducted to identify RCTs up until 5 October 2023. The outcomes included the levels of sex hormones, antral follicle count (AFC), Kupperman score, and total effective rate. The risk of bias (RoB) tool was utilized to evaluate the quality of the included studies. In order to guarantee the robustness and reliability of the findings, subgroup and sensitivity analyses were performed to investigate potential sources of heterogeneity.

Results: A total of 13 RCTs comprising 775 patients were included in the study. Acupuncture demonstrated significant efficacy in reducing follicle-stimulating hormone (FSH) [SMD = 0.83, 95% CI (0.27, 1.39), = 92%, = 0.004], enhancing estradiol levels (E) [SMD = 0.50, 95% CI (0.07, 0.93), = 0.02, = 87%], and increasing anti-Müllerian hormone (AMH) [SMD = 0.24, 95% CI (0.05, 0.44), = 0.01, = 8%], as well as improving the overall effective rate [RR = 1.22, 95% CI (1.10, 1.35), < 0.01, = 14%]. Subgroup analysis revealed that compared with non-acupuncture therapy, the acupuncture with Chinese herbal medicine (CHM) and hormone replacement therapy (HRT) group exhibited a substantial reduction in FSH levels [SMD = 1.02, 95% CI (0.52, 1.51), = 60%, < 0.01]. Furthermore, the acupuncture with CHM group also exhibited a substantial reduction [SMD = 4.59, 95% CI (1.53, 7.65), = 98%, < 0.01]. However, only the acupuncture with CHM and HRT group demonstrated a significant increase in E levels [SMD = 0.55, 95% CI (0.23, 0.87), = 12%, 0.01].

Conclusion: Acupuncture has demonstrated superiority over non-acupuncture in diminishing serum FSH levels and increasing serum E, AMH, and the overall efficacy rate in women diagnosed with POI. These research findings suggest the necessity for broader-scale research with meticulous designs to fully demonstrate the efficacy and safety of acupuncture in the treatment of women with POI.

Systematic Review Registration: https://www.crd.york.ac.uk, identifier CRD42023467751.

Citing Articles

The effects of acupuncture on patients with premature ovarian insufficiency and polycystic ovary syndrome: an umbrella review of systematic reviews and meta-analyses.

Bai T, Deng X, Bi J, Ni L, Li Z, Zhuo X Front Med (Lausanne). 2024; 11:1471243.

PMID: 39655237 PMC: 11627218. DOI: 10.3389/fmed.2024.1471243.

References

Lin G, Liu X, Cong C, Chen S, Xu L . Clinical efficacy of acupuncture for diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2023; 14:1136121. PMC: 10433735. DOI: 10.3389/fendo.2023.1136121. View

Gunning M, Meun C, van Rijn B, Daan N, Roeters van Lennep J, Appelman Y . The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study. PLoS One. 2020; 15(3):e0229576. PMC: 7058320. DOI: 10.1371/journal.pone.0229576. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

Welt C . Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2007; 68(4):499-509. DOI: 10.1111/j.1365-2265.2007.03073.x. View

Zhou Y, Jin Y, Wu T, Wang Y, Dong Y, Chen P . New insights on mitochondrial heteroplasmy observed in ovarian diseases. J Adv Res. 2023; 65:211-226. PMC: 11519015. DOI: 10.1016/j.jare.2023.11.033. View

Ishizuka B . Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI). Front Endocrinol (Lausanne). 2021; 12:626924. PMC: 7949002. DOI: 10.3389/fendo.2021.626924. View

Tao M, Shao H, Li C, Teng Y . Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient Prefer Adherence. 2013; 7:223-9. PMC: 3615846. DOI: 10.2147/PPA.S42852. View

Cattoni A, Parissone F, Porcari I, Molinari S, Masera N, Franchi M . Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations. Blood Rev. 2020; 45:100730. DOI: 10.1016/j.blre.2020.100730. View

Tan R, He Y, Zhang S, Pu D, Wu J . Effect of transcutaneous electrical acupoint stimulation on protecting against radiotherapy- induced ovarian damage in mice. J Ovarian Res. 2019; 12(1):65. PMC: 6642573. DOI: 10.1186/s13048-019-0541-1. View

10.

Chemaitilly W, Li Z, Krasin M, Brooke R, Wilson C, Green D . Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report From the St. Jude Lifetime Cohort. J Clin Endocrinol Metab. 2017; 102(7):2242-2250. PMC: 5505200. DOI: 10.1210/jc.2016-3723. View

11.

Booyens R, Engelbrecht A, Strauss L, Pretorius E . To clot, or not to clot: The dilemma of hormone treatment options for menopause. Thromb Res. 2022; 218:99-111. DOI: 10.1016/j.thromres.2022.08.016. View

12.

Xi D, Chen B, Tao H, Xu Y, Chen G . The risk of depressive and anxiety symptoms in women with premature ovarian insufficiency: a systematic review and meta-analysis. Arch Womens Ment Health. 2023; 26(1):1-10. PMC: 9908676. DOI: 10.1007/s00737-022-01289-7. View

13.

Hugh M, Altman D, Hammerschlag R, Li Y, Wu T, White A . [Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement (Chinese version)]. Zhong Xi Yi Jie He Xue Bao. 2010; 8(9):804-18. DOI: 10.3736/jcim20100902. View

14.

Li H, Zhang J, Chen W . Dissecting the efficacy of the use of acupuncture and Chinese herbal medicine for the treatment of premature ovarian insufficiency (POI): A systematic review and metaanalysis. Heliyon. 2023; 9(10):e20498. PMC: 10560776. DOI: 10.1016/j.heliyon.2023.e20498. View

15.

Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S . Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci U S A. 2013; 110(43):17474-9. PMC: 3808580. DOI: 10.1073/pnas.1312830110. View

16.

Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B . ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016; 31(5):926-37. DOI: 10.1093/humrep/dew027. View

17.

Cuzick J, Chu K, Keevil B, Brentnall A, Howell A, Zdenkowski N . Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial. Lancet Oncol. 2023; 25(1):108-116. DOI: 10.1016/S1470-2045(23)00578-8. View

18.

Li Y, Xia G, Tan Y, Shuai J . Acupoint stimulation and Chinese herbal medicines for the treatment of premature ovarian insufficiency: A systematic review and meta-analysis. Complement Ther Clin Pract. 2020; 41:101244. DOI: 10.1016/j.ctcp.2020.101244. View

19.

Geng Z, Liu P, Yuan L, Zhang K, Lin J, Nie X . Electroacupuncture attenuates ac4C modification of P16 mRNA in the ovarian granulosa cells of a mouse model premature ovarian failure. Acupunct Med. 2022; 41(1):27-37. DOI: 10.1177/09645284221085284. View

20.

Xu C, Li H, Fang Y, Bai T, Yu X . [Effect of regulating menstruation and promoting pregnancy acupuncture therapy on negative emotion in patients with premature ovarian insufficiency]. Zhongguo Zhen Jiu. 2021; 41(3):279-82. DOI: 10.13703/j.0255-2930.20200307-0004. View